Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat

Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation

(2016) Jeff A. Beeler et al.   BIOLOGICAL PSYCHIATRY

Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

(2016) Richard Weisler et al.   CNS SPECTRUMS

The Nucleus Accumbens: An Interface Between Cognition, Emotion, and Action

(2015) Stan B. Floresco   Annual Review of Psychology

Dopamine enhances willingness to exert effort for reward in Parkinson's disease

(2015) Trevor T.-J. Chong et al.   CORTEX

Neurobiological basis of motivational deficits in psychopathology

(2015) John D. Salamone et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Levodopa Reverses Cytokine-Induced Reductions in Striatal Dopamine Release

(2015) Jennifer C. Felger et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior

(2015) Samantha E Yohn et al.   NEUROPSYCHOPHARMACOLOGY

The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists

(2015) Samantha E. Yohn et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists

(2015) Marta Pardo et al.   PSYCHOPHARMACOLOGY

Bupropion Increases Selection of High Effort Activity in Rats Tested on a Progressive Ratio/Chow Feeding Choice Procedure: Implications for Treatment of Effort-Related Motivational Symptoms

(2015) P. A. Randall et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats

(2014) S. Sommer et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Predictors of Response to Adjunctive Osmotic-Release Methylphenidate or Placebo in Patients With Major Depressive Disorder

(2014) Sakina J. Rizvi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Dopamine Antagonism Decreases Willingness to Expend Physical, But Not Cognitive, Effort: A Comparison of Two Rodent Cost/Benefit Decision-Making Tasks

(2014) Jay G Hosking et al.   NEUROPSYCHOPHARMACOLOGY

The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio/Chow Feeding Choice Task: Reversal with Antidepressant Drugs

(2014) Patrick A. Randall et al.   PLoS One

The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion

(2014) Samantha E. Yohn et al.   PSYCHOPHARMACOLOGY

The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder

(2013) Anthony J. Rothschild et al.   COMPREHENSIVE PSYCHIATRY

CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN MAJOR DEPRESSIVE DISORDER

(2013) Maurizio Fava et al.   DEPRESSION AND ANXIETY

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer’s Disease

(2013) Paul B. Rosenberg et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effort-Related Motivational Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Animal Models of the Motivational Symptoms of Depression

(2013) E. J. Nunes et al.   JOURNAL OF NEUROSCIENCE

Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union

(2013) James A Cooper et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases

(2013) Robert A Lasser et al.   NEUROPSYCHOPHARMACOLOGY

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

(2013) J.C. Felger et al.   NEUROSCIENCE

Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: Effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors

(2013) Eric J. Nunes et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation

(2013) Takayuki Tanno et al.   PSYCHOPHARMACOLOGY

Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task

(2013) Eric J. Nunes et al.   PSYCHOPHARMACOLOGY

Reversal of SSRI-Associated Apathy Syndrome by Discontinuation of Therapy

(2012) Prasad R Padala et al.   ANNALS OF PHARMACOTHERAPY

Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature

(2012) Jack J. Chen et al.   CLINICAL THERAPEUTICS

Methylphenidate

(2012) David Devos et al.   CNS DRUGS

Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise

(2012) Jennifer C. Felger et al.   FRONTIERS IN NEUROENDOCRINOLOGY

The Behavioral Pharmacology of Effort-related Choice Behavior: Dopamine, Adenosine and Beyond

(2012) John D Salamone et al.   JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR

Increased monoaminergic neurotransmission improves compliance with physical activity recommendations in depressed patients with fatigue

(2012) Emelie Stenman et al.   MEDICAL HYPOTHESES

Translational approaches to treatment-induced symptoms in cancer patients

(2012) Robert Dantzer et al.   Nature Reviews Clinical Oncology

The Mysterious Motivational Functions of Mesolimbic Dopamine

(2012) John D. Salamone et al.   NEURON

Lisdexamfetamine and immediate release d-amfetamine – Differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity

(2012) H.L. Rowley et al.   NEUROPHARMACOLOGY

Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice

(2012) M. Pardo et al.   NEUROPHARMACOLOGY

Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual Differences

(2012) Patrick A. Randall et al.   PLoS One

Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: A double blind, placebo-controlled study

(2012) Joel L. Young   PSYCHIATRY RESEARCH

Motivational states influence effort-based decision making in rats: The role of dopamine in the nucleus accumbens

(2011) Bettina Mai et al.   COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE

Amping Up Effort: Effects of d-Amphetamine on Human Effort-Based Decision-Making

(2011) M. C. Wardle et al.   JOURNAL OF NEUROSCIENCE

Effects of Methylphenidate on Fatigue and Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

(2011) Christopher W. Kerr et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders

(2010) David R.P. Guay   American Journal Geriatric Pharmacotherapy

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

(2010) Lawrence S. Kegeles et al.   ARCHIVES OF GENERAL PSYCHIATRY

Reconsidering anhedonia in depression: Lessons from translational neuroscience

(2010) Michael T. Treadway et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease

(2010) Julie L. Wang et al.   NUCLEAR MEDICINE AND BIOLOGY

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease

(2010) Samuel Frank   Neuropsychiatric Disease and Treatment

Dopamine modulates effort-based decision making in rats.

(2009) Mark E. Bardgett et al.   BEHAVIORAL NEUROSCIENCE

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

(2009) Samuel Frank   BMC Neurology

The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults

(2009) Jadwiga Najib   CLINICAL THERAPEUTICS

Cytokine, Sickness Behavior, and Depression

(2009) Robert Dantzer   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Osmotic-Release Oral System Methylphenidate Augmentation of Antidepressant Monotherapy in Major Depressive Disorder

(2009) Arun V. Ravindran et al.   JOURNAL OF CLINICAL PSYCHIATRY

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

(2009) Allison M. Mott et al.   PSYCHOPHARMACOLOGY

Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface

(2008) Andrew H. Miller   BRAIN BEHAVIOR AND IMMUNITY